HDL Therapeutics, a clinical stage company and an emerging leader in the field of reversing coronary atherosclerosis, today announced positive data from the company's registrational trial for its...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the latest research from its robust oncology portfolio and pipeline to be presented at the 2019 American Society of...

Bayer today announced findings from new analyses and data for Vitrakvi® (larotrectinib), which is approved for the treatment of adult and pediatric patients with solid tumors that have a...

Amgen (NASDAQ: AMGN) today announced that data from its oncology pipeline will be presented at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 31-June...

Eli Lilly and Company (NYSE: LLY) today announced that data from a number of studies across the company's oncology product portfolio will be presented at the 55th Annual Meeting of the American...

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the RBC Annual Healthcare Conference in New York City on Tuesday, May 21,...

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the publication of data abstracts related to two of MEI Pharma's...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it will present new data for several investigational compounds in the Daiichi Sankyo oncology pipeline at the 2019...

Stoneridge, Inc. (NYSE: SRI) today announced that Robert R. Krakowiak, chief financial officer, and Matthew R. Horvath, director of corporate development and investor relations, will participate...

Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced participation in the following scientific, medical, and investor conferences: Upcoming Medical & Scientific...